Role of parathyroid hormone-related peptide in hypercalcemia of malignancy and the development of osteolytic metastases.
de Vernejoul
M C
MC
Rheumatology Department, Lariboisière Teaching Hospital, Paris, France.
D001859:Bone Neoplasms / Q000188:drug therapy / Q000503:physiopathology / Q000556:secondary*; D004164:Diphosphonates / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D008297:Male; D009363:Neoplasm Proteins / Q000502:physiology*; D009369:Neoplasms / Q000150:complications* / Q000503:physiopathology; D010014:Osteolysis / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*; D044162:Parathyroid Hormone-Related Protein; D011379:Prognosis; D011506:Proteins / Q000502:physiology*; D018016:Receptors, Parathyroid Hormone / Q000378:metabolism
D004164:Diphosphonates; D009363:Neoplasm Proteins; C470121:PTHLH protein, human; D044162:Parathyroid Hormone-Related Protein; D011506:Proteins; D018016:Receptors, Parathyroid Hormone